| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.44 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.26 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |